FDA Inspection 1169384 — Unicare Biomedical, Inc.
The FDA completed an inspection of Unicare Biomedical, Inc. on May 11, 2022 in Laguna Hills, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 11, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Laguna Hills, CA (United States)